Free Trial

167,184 Shares in Core Scientific, Inc. (NASDAQ:CORZ) Acquired by Harbor Capital Advisors Inc.

Core Scientific logo with Finance background

Harbor Capital Advisors Inc. purchased a new stake in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 167,184 shares of the company's stock, valued at approximately $1,210,000. Harbor Capital Advisors Inc. owned 0.06% of Core Scientific as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CORZ. KLP Kapitalforvaltning AS purchased a new stake in Core Scientific in the 4th quarter worth approximately $527,000. Stephens Inc. AR purchased a new stake in Core Scientific during the fourth quarter valued at about $927,000. Van ECK Associates Corp grew its position in Core Scientific by 26.1% during the 4th quarter. Van ECK Associates Corp now owns 2,039,718 shares of the company's stock worth $28,658,000 after acquiring an additional 422,774 shares during the last quarter. Deutsche Bank AG grew its holdings in shares of Core Scientific by 53.8% in the fourth quarter. Deutsche Bank AG now owns 165,032 shares of the company's stock worth $2,319,000 after purchasing an additional 57,742 shares during the last quarter. Finally, New York State Common Retirement Fund increased its position in shares of Core Scientific by 30.7% in the fourth quarter. New York State Common Retirement Fund now owns 187,181 shares of the company's stock valued at $2,630,000 after acquiring an additional 43,915 shares during the period.

Insider Activity

In other news, Director Yadin Rozov purchased 110,000 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The shares were bought at an average cost of $10.87 per share, for a total transaction of $1,195,700.00. Following the acquisition, the director now owns 475,687 shares of the company's stock, valued at approximately $5,170,717.69. This trade represents a 30.08% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Todd M. Duchene sold 50,000 shares of the company's stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $12.31, for a total value of $615,500.00. Following the transaction, the insider now directly owns 2,050,102 shares in the company, valued at approximately $25,236,755.62. This represents a 2.38% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.40% of the company's stock.

Analysts Set New Price Targets

CORZ has been the topic of several research analyst reports. JMP Securities assumed coverage on Core Scientific in a research note on Thursday, May 22nd. They set a "market outperform" rating and a $15.00 target price on the stock. Canaccord Genuity Group reaffirmed a "buy" rating and issued a $17.00 price target on shares of Core Scientific in a research report on Friday, May 9th. Cantor Fitzgerald lowered their price objective on Core Scientific from $24.00 to $21.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Oppenheimer began coverage on shares of Core Scientific in a report on Wednesday, May 14th. They set an "outperform" rating and a $15.00 price target on the stock. Finally, Compass Point cut their price objective on Core Scientific from $26.00 to $20.00 and set a "buy" rating for the company in a report on Tuesday, February 25th. Eighteen research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Core Scientific currently has a consensus rating of "Buy" and an average price target of $18.44.

View Our Latest Report on Core Scientific

Core Scientific Stock Down 2.1%

NASDAQ:CORZ traded down $0.25 on Friday, reaching $11.89. 5,602,988 shares of the company's stock traded hands, compared to its average volume of 12,964,163. The stock has a 50-day simple moving average of $9.37 and a 200-day simple moving average of $11.41. The firm has a market cap of $3.54 billion, a PE ratio of -2.20 and a beta of 6.30. Core Scientific, Inc. has a 12 month low of $6.20 and a 12 month high of $18.63.

Core Scientific (NASDAQ:CORZ - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.02. The company had revenue of $79.53 million during the quarter, compared to the consensus estimate of $92.04 million. During the same quarter in the prior year, the firm posted $0.78 earnings per share. The business's revenue was down 55.6% on a year-over-year basis. On average, equities analysts anticipate that Core Scientific, Inc. will post 0.52 earnings per share for the current year.

Core Scientific Company Profile

(Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Recommended Stories

Institutional Ownership by Quarter for Core Scientific (NASDAQ:CORZ)

Should You Invest $1,000 in Core Scientific Right Now?

Before you consider Core Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.

While Core Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines